The Department of Energy’s semiautonomous National Nuclear Security Administration has awarded $10 million in Phase II funding to SHINE Medical Technologies as part of the agency’s domestic supply program for molybdenum-99 (mo-99).
The funding is part…
SUBSCRIBER ACCESS
Thank you for visiting
Weapons Complex Morning Briefing!
You must be logged in as a subscriber to view this page.
